HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


P&G Abandons Billie Acquisition; Coty Board Changes; Beauty News In Brief

Executive Summary

P&G and women’s razor competitor Billie call off their proposed combination after the FTC made initial moves in December to prevent the deal, deeming it not in consumers’ interest. More cosmetics industry news in brief.

You may also be interested in...

P&G’s Planned Billie Acquisition? Not So Fast, FTC Says

Less than a year after the US FTC put the skids on Edgewell’s intended acquisition of Harry’s, it is intervening to stop P&G from buying women’s razor startup Billie. “If P&G can snuff out Billie’s rapid competitive growth, consumers will likely face higher prices,” FTC leadership says.

Edgewell Without Harry’s: Strategic Path Remains The Same, Just A Longer Road Now

One week after the FTC challenged the deal as anticompetitive, Edgewell announced on 10 February that it has terminated its merger agreement with direct-to-consumer upstart Harry’s. The firm remains focused on improving its underlying business and says its first-quarter results, posted the same day, show that its strategy is working.

Natura Making Strong Headway In The Body Shop Transformation; Next Up, Avon

The Brazilian beauty giant reported 8.8% growth in The Body Shop sales in the fiscal 2019 first half, driven by strong gains in the UK and other key markets, offsetting the effect of 37 store closures in the past year as part of Natura’s transformation plan for the business. Meanwhile, incoming acquiree Avon is seeing better productivity, though sales continued to fall in the firm’s second quarter.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts